These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 34724254)

  • 1. Coronary imaging of cardiac allograft vasculopathy predicts current and future deterioration of left ventricular function in patients with orthotopic heart transplantation.
    Reddy SA; Khialani BV; Lambert B; Floré V; Brown AJ; Pettit SJ; West NE; Lewis C; Parameshwar J; Bhagra S; Kydd A; Hoole SP
    Clin Transplant; 2022 Feb; 36(2):e14523. PubMed ID: 34724254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optical coherence tomography for characterization of cardiac allograft vasculopathy in late survivors of pediatric heart transplantation.
    Tomai F; De Luca L; Petrolini A; Di Vito L; Ghini AS; Corvo P; De Persio G; Parisi F; Pongiglione G; Giulia Gagliardi M; Prati F
    J Heart Lung Transplant; 2016 Jan; 35(1):74-79. PubMed ID: 26452998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intravascular ultrasound for cardiac allograft vasculopathy detection.
    Mendiz OA; Gamboa P; Renedo MF; Lev GA; Favaloro LE; Bertolotti AM
    Clin Transplant; 2021 Feb; 35(2):e14167. PubMed ID: 33237578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. European Association of Cardiovascular Imaging/Cardiovascular Imaging Department of the Brazilian Society of Cardiology recommendations for the use of cardiac imaging to assess and follow patients after heart transplantation.
    Badano LP; Miglioranza MH; Edvardsen T; Colafranceschi AS; Muraru D; Bacal F; Nieman K; Zoppellaro G; Marcondes Braga FG; Binder T; Habib G; Lancellotti P;
    Eur Heart J Cardiovasc Imaging; 2015 Sep; 16(9):919-48. PubMed ID: 26139361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravascular ultrasound-guided selection for early noninvasive cardiac allograft vasculopathy screening in heart transplant recipients.
    Nelson LM; Rossing K; Ihlemann N; Boesgaard S; Engstrøm T; Gustafsson F
    Clin Transplant; 2020 Dec; 34(12):e14124. PubMed ID: 33068292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How to Approach the Assessment of Cardiac Allograft Vasculopathy in the Modern Era: Review of Invasive Imaging Modalities.
    Javaheri A; Saha N; Lilly SM
    Curr Heart Fail Rep; 2016 Apr; 13(2):86-91. PubMed ID: 26879390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between markers of plaque vulnerability in optical coherence tomography and atherosclerotic progression in adult patients with heart transplantation.
    Park KH; Sun T; Liu Z; Yang SW; Lennon RJ; Lerman LO; Kushwaha SS; Lerman A
    J Heart Lung Transplant; 2017 Feb; 36(2):185-192. PubMed ID: 27461884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Layered Fibrotic Plaques Are the Predominant Component in Cardiac Allograft Vasculopathy: Systematic Findings and Risk Stratification by OCT.
    Clemmensen TS; Holm NR; Eiskjær H; Løgstrup BB; Christiansen EH; Dijkstra J; Barkholt TØ; Terkelsen CJ; Maeng M; Poulsen SH
    JACC Cardiovasc Imaging; 2017 Jul; 10(7):773-784. PubMed ID: 28330670
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optical coherence tomography and highly sensitivity troponin T for evaluating cardiac allograft vasculopathy.
    Garrido IP; García-Lara J; Pinar E; Pastor-Pérez F; Sánchez-Mas J; Valdés-Chavarri M; Pascual-Figal DA
    Am J Cardiol; 2012 Sep; 110(5):655-61. PubMed ID: 22640973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optical Coherence Tomography for the Early Detection of Coronary Vascular Changes in Children and Adolescents After Cardiac Transplantation: Findings From the International Pediatric OCT Registry.
    McGovern E; Hosking MCK; Balbacid E; Voss C; Berger F; Schubert S; Harris KC
    JACC Cardiovasc Imaging; 2019 Dec; 12(12):2492-2501. PubMed ID: 30031706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary atherosclerosis with vulnerable plaque and complicated lesions in transplant recipients: new insight into cardiac allograft vasculopathy by optical coherence tomography.
    Cassar A; Matsuo Y; Herrmann J; Li J; Lennon RJ; Gulati R; Lerman LO; Kushwaha SS; Lerman A
    Eur Heart J; 2013 Sep; 34(33):2610-7. PubMed ID: 23801824
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for early development of cardiac allograft vasculopathy by intravascular ultrasound.
    Moayedi Y; Fan CPS; Tremblay-Gravel M; Miller RJH; Kawana M; Henricksen E; Parizo J; Wainwright R; Fearon WF; Ross HJ; Khush KK; Teuteberg JJ
    Clin Transplant; 2020 Nov; 34(11):e14098. PubMed ID: 32970884
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronary computed tomography in heart transplant patients: detection of significant stenosis and cardiac allograft vasculopathy, image quality, and radiation dose.
    Günther A; Aaberge L; Abildgaard A; Ragnarsson A; Edvardsen T; Jakobsen J; Andersen R
    Acta Radiol; 2018 Sep; 59(9):1066-1073. PubMed ID: 29260577
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravascular ultrasound of the proximal left anterior descending artery is sufficient to detect early cardiac allograft vasculopathy.
    Floré V; Brown AJ; Pettit SJ; West NEJ; Lewis C; Parameshwar J; Hoole SP
    Clin Transplant; 2018 Feb; 32(2):. PubMed ID: 29194769
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PET Assessment of Epicardial Intimal Disease and Microvascular Dysfunction in Cardiac Allograft Vasculopathy.
    Chih S; Chong AY; Erthal F; deKemp RA; Davies RA; Stadnick E; So DY; Overgaard C; Wells G; Mielniczuk LM; Beanlands RSB
    J Am Coll Cardiol; 2018 Apr; 71(13):1444-1456. PubMed ID: 29598865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive aortic pulse pressure is linked to cardiac allograft vasculopathy after heart transplantation.
    Park HW; Ozcan I; Toya T; Ahmad A; Kanaji Y; Kushwaha SS; Lerman LO; Lerman A
    Int J Cardiol; 2023 Jan; 370():167-174. PubMed ID: 36346255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety of optical coherence tomography in pediatric heart transplant patients.
    Ulrich SM; Lehner A; Birnbaum J; Heckel S; Haas NA; Hakami L; Schramm R; Dalla Pozza R; Fischer M; Kozlik-Feldmann R
    Int J Cardiol; 2017 Feb; 228():205-208. PubMed ID: 27866017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuated-Signal Plaque Progression Predicts Long-Term Mortality After Heart Transplantation: IVUS Assessment of Cardiac Allograft Vasculopathy.
    Okada K; Fearon WF; Luikart H; Kitahara H; Otagiri K; Tanaka S; Kimura T; Yock PG; Fitzgerald PJ; Yeung AC; Valantine HA; Khush KK; Honda Y
    J Am Coll Cardiol; 2016 Jul; 68(4):382-92. PubMed ID: 27443435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravascular ultrasound for assessment of coronary allograft vasculopathy.
    König A; Theisen K; Klauss V
    Z Kardiol; 2000; 89 Suppl 9():IX/45-9. PubMed ID: 11151792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring of allograft vasculopathy by intravascular ultrasound one month and one year after heart transplantation: A single center study.
    Bedanova H; Orban M; Tretina M; Fila P; Horvath V; Krejci J; Nemec P
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Mar; 160(1):130-5. PubMed ID: 26220510
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.